|
1
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 World Health Organization
Classification of Tumors of the Central Nervous System: A summary.
Acta Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mackay A, Burford A, Carvalho D, Izquierdo
E, Fazal-Salom J, Taylor KR, Bjerke L, Clarke M, Vinci M,
Nandhabalan M, et al: integrated molecular meta-analysis of 1,000
pediatric high-grade and diffuse intrinsic pontine glioma. Cancer
Cell. 32:520–537.e5. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ostrom QT, Price M, Ryan K, Edelson J,
Neff C, Cioffi G, Waite KA, Kruchko C and Barnholtz-Sloan JS:
CBTRUS statistical report: Pediatric brain tumor foundation
childhood and adolescent primary brain and other central nervous
system tumors diagnosed in the United States in 2014–2018. Neuro
Oncol. 24 (Suppl 3):iii1–1iii38. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hamilton JD, Rapp M, Schneiderhan T, Sabel
M, Hayman A, Scherer A, Kröpil P, Budach W, Gerber P, Kretschmar U,
et al: Glioblastoma multiforme metastasis outside the CNS: Three
case reports and possible mechanisms of escape. J Clin Oncol.
32:e80–e84. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Beauchesne P: Extra-neural metastases of
malignant gliomas: Myth or reality? Cancers (Basel). 3:461–477.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Stephens S, Tollesson G, Robertson T and
Campbell R: Diffuse midline glioma metastasis to the peritoneal
cavity via ventriculo-peritoneal shunt: Case report and review of
literature. J Clin Neurosci. 67:288–293. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bhatt NS, Houser K, Belongia M, Ellison
DW, Foy A, Jarzembowski J, Kelly T, Maheshwari M, Suchi M and
Knipstein J: Diffuse midline glioma with osseous metastases at
diagnosis: A case report. J Pediatr Hematol Oncol. 42:e673–e676.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Handis C, Tanrıkulu B, Danyeli AE and Özek
MM: Spinal intramedullary H3K27M mutant glioma with vertebral
metastasis: A case report. Childs Nerv Syst. 37:3933–3937. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lazow MA, Leach JL, Trout AT, Breneman JC,
Fouladi M and Fuller C: Extraneural metastases of diffuse midline
glioma, H3 K27M-Mutant at diagnosis: Case report, review of the
literature, and identifying targetable alterations. J Pediatr
Hematol Oncol. 44:e597–e604. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mohiuddin S, Maraka S, Usman Baig M, Gupta
S, Muzzafar T, Valyi-Nagy T, Lindsay H, Moody K, Razvi S, Paulino
A, et al: Case series of diffuse extraneural metastasis in H3F3A
mutant high-grade gliomas: Clinical, molecular phenotype and
literature review. J Clin Neurosci. 89:405–411. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chukwueke UN and Wen PY: Use of the
Response Assessment in Neuro-Oncology (RANO) criteria in clinical
trials and clinical practice. CNS Oncol. 8:CNS282019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yi S, Choi S, Shin DA, Kim DS, Choi J, Ha
Y, Kim KN, Suh CO, Chang JH, Kim SH and Yoon DH: Impact of H3.3
K27M mutation on prognosis and survival of grade IV spinal cord
glioma on the basis of New 2016 World Health Organization
classification of the central nervous system. Neurosurgery.
84:1072–1081. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Karremann M, Gielen GH, Hoffmann M, Wiese
M, Colditz N, Warmuth-Metz M, Bison B, Claviez A, van Vuurden DG,
von Bueren AO, et al: Diffuse high-grade gliomas with H3 K27M
mutations carry a dismal prognosis independent of tumor location.
Neuro Oncol. 20:123–131. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bondy ML, Scheurer ME, Malmer B,
Barnholtz-Sloan JS, Davis FG, Il'yasova D, Kruchko C, McCarthy BJ,
Rajaraman P, Schwartzbaum JA, et al: Brain tumor epidemiology:
Consensus from the Brain tumor epidemiology consortium. Cancer. 113
(7 Suppl):S1953–S1968. 2008. View Article : Google Scholar
|
|
15
|
Ostrom QT, Gittleman H, Fulop J, Liu M,
Blanda R, Kromer C, Wolinsky Y, Kruchko C and Barnholtz-Sloan JS:
CBTRUS statistical report: Primary brain and central nervous system
tumors diagnosed in the United States in 2008–2012. Neuro Oncol. 17
(Suppl 4):iv1–1iv62. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jones C and Baker SJ: Unique genetic and
epigenetic mechanisms driving paediatric diffuse high-grade glioma.
Nat Rev Cancer. 14:10.1038/nrc3811. 2014. View Article : Google Scholar
|
|
17
|
Wu G, Broniscer A, McEachron TA, Lu C,
Paugh BS, Becksfort J, Qu C, Ding L, Huether R, Parker M, et al:
Somatic histone H3 alterations in pediatric diffuse intrinsic
pontine gliomas and non-brainstem glioblastomas. Nat Genet.
44:251–253. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lu VM, Alvi MA, McDonald KL and Daniels
DJ: Impact of the H3K27M mutation on survival in pediatric
high-grade glioma: A systematic review and meta-analysis. J
Neurosurg Pediatr. 23:308–316. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Navarro RE, Golub D, Hill T, McQuinn MW,
William C, Zagzag D and Hidalgo ET: Pediatric midline H3K27M-mutant
tumor with disseminated leptomeningeal disease and glioneuronal
features: Case report and literature review. Childs Nerv Syst.
37:2347–2356. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Y, Feng LL, Ji PG, Liu JH, Guo SC,
Zhai YL, Sankey EW, Wang Y, Xue YR, Wang N, et al: Clinical
features and molecular markers on diffuse midline gliomas With
H3K27M Mutations: A 43 cases retrospective cohort study. Front
Oncol. 10:6025532020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gamis AS, Egelhoff J, Roloson G, Young J,
Woods GM, Newman R and Freeman AI: Diffuse bony metastases at
presentation in a child with glioblastoma multiforme. A case
report. Cancer. 66:180–184. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Beauchesne P, Soler C and Mosnier JF:
Diffuse vertebral body metastasis from a glioblastoma multiforme: A
technetium-99m Sestamibi single-photon emission computerized
tomography study. J Neurosurg. 93:887–890. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Seoane J and De Mattos-Arruda L: Escaping
out of the brain. Cancer Discov. 4:1259–1261. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Piccirilli M, Brunetto GM, Rocchi G,
Giangaspero F and Salvati M: Extra central nervous system
metastases from cerebral glioblastoma multiforme in elderly
patients. Clinico-pathological remarks on our series of seven cases
and critical review of the literature. Tumori. 94:40–51. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bernstein JJ and Woodard CA: Glioblastoma
cells do not intravasate into blood vessels. Neurosurgery.
36:124–132; discussion 132. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Goodwin CR, Liang L, Abu-Bonsrah N, Hdeib
A, Elder BD, Kosztowski T, Bettegowda C, Laterra J, Burger P and
Sciubba DM: Extraneural glioblastoma multiforme vertebral
metastasis. World Neurosurg. 89:578–582.e3. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Smith HL, Wadhwani N and Horbinski C:
Major Features of the 2021 WHO Classification of CNS Tumors.
Neurotherapeutics. 19:1691–1704. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li ZG, Zheng MY, Zhao Q, Liu K, Du JX and
Zhang SW: Solitary vertebral metastatic glioblastoma in the absence
of primary brain tumor relapse: A case report and literature
review. BMC Med Imaging. 20:892020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang W, Cai YY, Wang XL, Wang XX, Li Y,
Han GY, Chu YJ, Zhang YX and Hao FR: Bone metastases of
glioblastoma: A case report and review of the literature. Front
Oncol. 11:7054552021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jiang H, Yang K, Ren X, Cui Y, Li M, Lei Y
and Lin S: Diffuse midline glioma with H3 K27M mutation: A
comparison integrating the clinical, radiological, and molecular
features between adult and pediatric patients. Neuro Oncol.
22:e1–1e9. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Long W, Yi Y, Chen S, Cao Q, Zhao W and
Liu Q: Potential new therapies for pediatric diffuse intrinsic
pontine glioma. Front Pharmacol. 8:4952017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ramaswamy V, Remke M and Taylor MD: An
epigenetic therapy for diffuse intrinsic pontine gliomas. Nat Med.
20:1378–1379. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wiese M, Schill F, Sturm D, Pfister S,
Hulleman E, Johnsen SA and Kramm CM: No significant cytotoxic
effect of the EZH2 inhibitor tazemetostat (EPZ-6438) on pediatric
glioma cells with wildtype histone 3 or mutated histone 3.3. Klin
Padiatr. 228:113–117. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang G, Fang Y, Zhou M, Li W, Dong D, Chen
J, Da Y, Wang K, Li X, Zhang X, et al: Case report: The effective
response to pembrolizumab in combination with bevacizumab in the
treatment of a recurrent glioblastoma with multiple extracranial
metastases. Front Oncol. 12:9489332022. View Article : Google Scholar : PubMed/NCBI
|
